Global eClinical Solutions and Software Industry Poised for Exponential Growth, Anticipates US$ 29.1 Billion Valuation by 2033 | FMI Insights

The Global Eclinical Solutions And Software Industry is set to undergo unprecedented expansion, projecting a staggering valuation of US$ 29.1 billion by the year 2033, a substantial surge from an estimated US$ 9.3 billion in 2023. The market, which exhibited robust growth with a Compound Annual Growth Rate (CAGR) of 10.6% between 2017 and 2022 (valued at US$ 8.4 billion in 2022), is poised for even greater heights with an impressive CAGR of 12.1% expected from 2023 to 2033.

This growth can be attributed to the surge in funding for clinical research and life sciences will enable the widespread usage of eClinical solutions and software which, in turn, will promote the overall market growth during the forecast period.

The expansion of research and development activities by biopharmaceutical and pharmaceutical businesses will prompt the use of eClinical solutions and software in various clinical trials which will foster growth for the market. This is primarily due to the fact that in order to address certain contemporary eClinical trial management needs, many businesses will require a comprehensive eClinical platform that will adapt to required needs. Hence, the prospects for the Global eClinical Solutions and Software Industry look bright in the upcoming years.

Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14416

With the surge in the amount of data produced via the clinical development process, the need for efficient tracking and evaluation of clinical data will also rise. As a result of this, the demand for eClinical solutions and software amplifies in clinical trials which, in turn, supplements the overall market growth. The eClinical solutions and software increase efficiency, lessen the expenditure, and errors like duplicate entry are avoided due to the use of eClinical technologies. This factor bodes well for the expansion of the Global eClinical Solutions and Software Industry size. Other factors that will aid the market growth are the progress witnessed in the life sciences field and the outsourcing of clinical trials to contract research organizations (CROs). All of these factors propel the Global eClinical Solutions and Software Industry forward during the projection period.

Key Takeaways:

• High costs and constant maintenance expenditure will prevent the growth of the eClinical solutions and software market during the assessment period.
• Based on the service, the clinical data management systems (CDMS) category will dominate the global market with an estimated share of 22.6% for 2023 and 2033.
• By delivery mode, the web-hosted (on-demand) will lead the market with a share of 67.3%.
• The eClinical solutions and software market in the US will hold about 39.3% of the market share in 2023 due to increasing product launches by key players.
• China’s eClinical solutions and software market will expand at a strong CAGR of 8.7% owing to greater medical needs.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14416

Competitive Landscape 

Oracle, Datatrak International, Inc., CRF Health, eClinicalWorks, Parexel International Corporation, Bioclinica, IBM Watson Health, and Anju Life Sciences Software, among others, are some of the dominant players in the Global eClinical Solutions and Software Industry profiled in the full version of the report.

In an intensely competitive environment, leading market players are concentrating on the swift adoption of advancing technology. These businesses employ various expansion strategies including mergers, collaborations, partnerships, and acquisitions, while also engaging in product development to enhance their market positions.

More Insights Into Global eClinical Solutions and Software Industry

In its latest report, FMI offers an unbiased and detailed analysis of the Global eClinical Solutions and Software Industry, providing historical data from 2017 to 2022 and forecast statistics for 2023 to 2033. For a comprehensive understanding of the global market potential, growth, and scope, the market is segmented on the basis of solution, delivery mode, clinical trial, end-user, and region.

According to the same reports, based on segmentation, the CROs category will make substantial contributions to the overall market growth in terms of end-users. In terms of clinical trials, the phase III segment will account for 46.7% of the global market share in 2023.

Based on region, the Global eClinical Solutions and Software Industry will present strong growth in the US. The target market in this region will account for 39.3% of the market share in 2023 and will likely continue this growth during the forecast period. Favorable government policies and rising funds from the government as well as increasing product launches from key players will push the market forward in the US. Germany and China, too, will make notable contributions to the global growth of the eClinical solutions and software market during the forecast period.

Tap into Comprehensive Segmented Information – Purchase Now
https://www.futuremarketinsights.com/checkout/14416

Key Players:

1. Oracle
2. Datatrak International, Inc.
3. Dassault Systemes
4. CRF Health
5. eClinicalWorks
6. Parexel International Corporation
7. Bioclinica
8. eClinical Solutions
9. IBM Watson Health
10. Anju Life Sciences Software
11. ERT Clinical

Key Market Segments Covered in Global eClinical Solutions and Software Industry Research

Solution:

• Randomization & Trial Management (RTSM)
• Clinical Data Management System (CDSM)
• Clinical Trial Management System (CLMS)
• Electronic Clinical Outcome Assessment (eCOA)
• Electronic Trial Master File (eTMF)
• Electronic Data Capture
• Others

Delivery Mode:

• Licensed Enterprise (On-premise) Solution
• Cloud-based (SAAS) Solution
• Web-hosted (on-demand) Solution

Clinical Trial:

• Phase I
• Phase II
• Phase III
• Phase IV

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube